Content Type: Research Publications

Constructing Opioid Legitimacy: The Canadian Pain Task Force’s Framing of the Overdose Crisis

March 6, 2026

Discovering a Transformative Cancer Drug: The Case of Ibrutinib

March 6, 2026

Estimating Racial and Ethnic Disparities in Substance Use Disorder Treatment and Harm Reduction Services: Findings From a Survey of People Who Use Drugs

March 6, 2026

Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval

March 6, 2026

Stigma, Scarcity and the Price of Legitimacy: Chronic Pain Advocacy and the Politics of Pharmaceutical Partnerships in Canada

March 6, 2026

Tertiary Patents on Drugs Approved By the FDA

March 6, 2026

Recent Changes in Discretionary Denials of Drug Patent Challenges

March 6, 2026

Therapeutic Value and Regulatory Characteristics of Breakthrough Therapy Drugs in the USA and China (2021-2023): A Retrospective Cohort Study

March 6, 2026

Real-World Evidence in Drug Approvals at the European Medicines Agency

March 6, 2026

Pricing Trends and Overlapping Indications of Checkpoint Inhibitors for Cancer Treatment

March 6, 2026

Patient and Population Impacts of Multigene Panel and Pembrolizumab Coverage in Metastatic Melanoma

March 6, 2026

Optimizing Oncology Drug Development: Systematic Review of 22 Years of Myeloma Randomized Controlled Trials

March 6, 2026